HDAC2 and hepatocellular carcinoma: The inhibition of HDAC2 activity increases histone acetylation of the MIR22HG promoter region, thereby up-regulating the expression of MIR22HG and miR-22-5p and increasing the radiosensitivity of HCC cells.